ILMN

273.90

7.25% 18.52

Dopo l'orario di chiusura: 273.92 0.02 +0.01%

Illumina Inc (ILMN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ILMN Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$255.38

Aprire:

$253.79

Volume 24 ore:

3.48M

Relative Volume:

1.39

Capitalizzazione di mercato:

$41.36B

Reddito:

$4.39B

Utile/perdita netta:

$853.00M

Rapporto P/E:

49.71

EPS:

5.5097

Flusso di cassa netto:

$556.00M

1 W Prestazione:

+11.71%

1M Prestazione:

+22.70%

6M Prestazione:

+117.42%

1 anno Prestazione:

+190.12%

Intervallo 1D:

$250.92

$277.95

Intervallo di 1 settimana:

$234.57

$277.95

Portata 52W:

$88.00

$277.95

Illumina Inc Stock (ILMN) Company Profile

Nome

Illumina Inc

Settore

Healthcare (1068)

Industria

Diagnostics & Research (49)

Telefono

(858) 202-4500

Indirizzo

5200 ILLUMINA WAY, SAN DIEGO, CA

Dipendente

8,650

Cinguettio

@illumina

Prossima data di guadagno

2026-10-29

Ultimi documenti SEC

ILMN's Discussions on Twitter

Compare ILMN vs TMO, DHR, NTRA, A, IQV

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ILMN Illumina Inc	273.90	38.56B	4.39B	853.00M	556.00M	5.5097
TMO Thermo Fisher Scientific Inc	678.39	245.99B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	223.77	155.75B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	408.79	56.33B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	172.84	46.61B	7.23B	1.41B	1.09B	4.979
IQV Iqvia Holdings Inc	275.02	44.09B	16.63B	1.39B	2.12B	8.0674

Illumina Inc Stock (ILMN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-12	Downgrade	Daiwa Securities	Outperform → Neutral
2025-07-11	Downgrade	Scotiabank	Sector Outperform → Sector Perform
2025-03-04	Reiterato	Citigroup	Neutral
2025-02-28	Downgrade	HSBC Securities	Buy → Hold
2025-02-10	Downgrade	Barclays	Equal Weight → Underweight
2025-02-07	Downgrade	TD Cowen	Buy → Hold
2024-12-11	Downgrade	Citigroup	Buy → Neutral
2024-11-12	Ripresa	Morgan Stanley	Equal-Weight
2024-10-17	Aggiornamento	HSBC Securities	Hold → Buy
2024-08-28	Aggiornamento	Argus	Hold → Buy
2024-08-16	Aggiornamento	Daiwa Securities	Neutral → Buy
2024-08-14	Aggiornamento	Barclays	Underweight → Equal Weight
2024-08-14	Aggiornamento	TD Cowen	Hold → Buy
2024-07-10	Aggiornamento	Citigroup	Neutral → Buy
2024-06-03	Ripresa	Jefferies	Hold
2024-01-16	Downgrade	HSBC Securities	Buy → Hold
2024-01-04	Downgrade	TD Cowen	Outperform → Market Perform
2023-12-18	Aggiornamento	Scotiabank	Sector Perform → Sector Outperform
2023-12-15	Aggiornamento	Bernstein	Underperform → Mkt Perform
2023-12-14	Iniziato	Guggenheim	Buy
2023-12-14	Iniziato	Stephens	Overweight
2023-12-13	Iniziato	Wolfe Research	Outperform
2023-12-12	Downgrade	BofA Securities	Neutral → Underperform
2023-12-11	Aggiornamento	Citigroup	Sell → Neutral
2023-11-10	Downgrade	Canaccord Genuity	Buy → Hold
2023-09-28	Iniziato	Bernstein	Underperform
2023-07-05	Ripresa	JP Morgan	Neutral
2023-01-25	Downgrade	Argus	Buy → Hold
2023-01-05	Iniziato	Scotiabank	Sector Perform
2022-12-12	Downgrade	Citigroup	Neutral → Sell
2022-12-07	Iniziato	RBC Capital Mkts	Outperform
2022-10-04	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2022-09-28	Aggiornamento	Evercore ISI	In-line → Outperform
2022-08-25	Iniziato	Credit Suisse	Neutral
2022-07-13	Downgrade	Barclays	Equal Weight → Underweight
2022-01-18	Aggiornamento	Stifel	Hold → Buy
2022-01-11	Aggiornamento	Barclays	Underweight → Equal Weight
2022-01-07	Aggiornamento	BofA Securities	Underperform → Neutral
2022-01-06	Ripresa	Morgan Stanley	Equal-Weight
2022-01-06	Ripresa	Piper Sandler	Overweight
2021-10-15	Ripresa	Cowen	Outperform
2021-08-19	Downgrade	SVB Leerink	Outperform → Mkt Perform
2021-06-01	Aggiornamento	Evercore ISI	Underperform → In-line
2021-03-31	Downgrade	Atlantic Equities	Overweight → Neutral
2021-03-31	Aggiornamento	Canaccord Genuity	Hold → Buy
2021-03-03	Iniziato	Barclays	Underweight
2020-12-22	Aggiornamento	Piper Sandler	Neutral → Overweight
2020-12-17	Aggiornamento	BTIG Research	Neutral → Buy
2020-10-13	Downgrade	Guggenheim	Buy → Neutral
2020-09-30	Iniziato	Atlantic Equities	Overweight
2020-09-29	Downgrade	Wolfe Research	Outperform → Peer Perform
2020-09-22	Downgrade	Stifel	Buy → Hold
2020-09-22	Downgrade	UBS	Buy → Neutral
2020-09-21	Aggiornamento	Guggenheim	Neutral → Buy
2020-09-21	Downgrade	JP Morgan	Overweight → Neutral
2020-09-09	Iniziato	Morgan Stanley	Equal-Weight
2020-08-07	Downgrade	Evercore ISI	In-line → Underperform
2020-08-07	Downgrade	Piper Sandler	Overweight → Neutral
2020-07-07	Downgrade	Guggenheim	Buy → Neutral
2020-04-24	Downgrade	Citigroup	Buy → Neutral
2020-04-21	Downgrade	Robert W. Baird	Outperform → Neutral
2020-01-08	Iniziato	Wells Fargo	Underweight
2020-01-07	Iniziato	Citigroup	Buy
2020-01-02	Downgrade	Evercore ISI	Outperform → In-line
2019-11-15	Iniziato	Stifel	Buy
2019-10-25	Iniziato	Guggenheim	Buy

Mostra tutto

Illumina Inc Borsa (ILMN) Ultime notizie

05:33 AM

A Look at Illumina Inc (ILMN) After 7.2% Gain -- GF Value $133.2 - GuruFocus

05:33 AM

03:15 AM

Illumina Inc Stock (ILMN) Moved Up by 7.45% on Sep 24: A Full Analysis - TradingKey

03:15 AM

10:50 AM

Illumina gains as recent index inclusion and stronger outlook appear to support shares - Quiver Quantitative

10:50 AM

10:00 AM

Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today - benzinga.com

Sep 22, 2026

Illumina stock holds near its yearly high as targets diverge - ad-hoc-news.de

Sep 22, 2026

Illumina stock heads into the open after a 2.27 percent drop - ad-hoc-news.de

Sep 22, 2026

Sep 21, 2026

Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate - Zacks Investment Research

Sep 21, 2026

Illumina Inc. stock gains S&P 500 spot after strong earnings beats - ad-hoc-news.de

Sep 21, 2026